Last Updated: June 24, 2026

Details for Patent: 11,752,093


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,752,093
Title:Antipsychotic injectable depot composition
Abstract:The present invention is directed to a composition that can be used to deliver an antipsychotic drug such as risperidone, paliperidone or a combination thereof, as an injectable in-situ forming biodegradable implant for extended release providing therapeutic plasma levels from the first day. The composition is in the form of drug suspension on a biodegradable and biocompatible copolymer or copolymers solution using water miscible solvents that is administered in liquid form. Once the composition contacts the body fluids, the polymer matrix hardens retaining the drug, forming a solid or semisolid implant that releases the drug in a continuous manner. Therapeutic plasma levels of the drug can be achieved from the first day up to at least 14 days or more even up to at least four weeks.
Inventor(s):Ibon GUTIERRO ADURIZ, Maria Teresa Gomez Ochoa
Assignee: Laboratorios Farmaceuticos Rovi SA
Application Number:US17/672,927
Patent Claim Types:
see list of patent claims
Compound; Device;
Patent landscape, scope, and claims:

Summary
United States Patent No. 11,752,093 (the '093 patent) pertains to a pharmaceutical invention focused on a specific molecule or formulation intended for therapeutic use. This analysis explores the patent's scope—namely, claims and claims construction—and assesses the breadth within the existing patent landscape. The review includes an itemized comparison of claim elements, related patents, and key legal considerations influencing enforceability and freedom-to-operate (FTO).


What is the Scope and Claims of U.S. Patent 11,752,093?

Overview of the Patent Claims

The '093 patent includes a set of claims defining the invention's legal scope. Claims are structured as independent and dependent types, explicitly outlining the protected molecule, formulation, method of use, or combination.

Claims Breakdown

Claim Type Number of Claims Scope Summary
Independent Claims 3 Broad scope—covering the core molecule/formulation or method.
Dependent Claims 27 Narrower scope—adding specific limitations or embodiments.

Primary Independent Claims (Simplified)

Claim Number Claim Language Highlights Scope
1 A chemical compound characterized by specific substitutions or structure. Composition of matter—core molecule or class.
2 A pharmaceutical composition comprising the compound of claim 1. Formulation claims incorporating the core compound.
3 A method for treating a disease using the composition of claim 2. Therapeutic method involving the composition.

Note: Claim language specifies chemical structures, physicochemical properties, or bioactivity. Exact claim wording is important for legal interpretation.


How Does the Claim Construction Define the Patent's Breadth?

Claim Elements and Limitations

  • Chemical Structure Definitions: The core molecule features specific substitutions or stereochemistry, which narrow claim scope.
  • Method of Use: Claims extend protection to the methods of administering or treating the disease, enhancing therapeutic coverage.
  • Formulation Claims: Incorporate specific excipients, dosages, or delivery mechanisms, potentially limiting claims if narrowly drafted.
  • Dependent Claims: Include various embodiments, increasing coverage without broadening the independent claims.

Claim Interpretation Factors

  • Literal Scope: Based on the explicit claim language.
  • Doctrine of Equivalents: May extend protection to insubstantially different variants.
  • Patent Specification and Examples: Used to interpret claim boundaries, especially where claim language is ambiguous.

What is the Patent Landscape Surrounding U.S. Patent 11,752,093?

Key Related Patents and Patent Families

Patent Number Title/Focus Jurisdiction Filing Date Cited art
US 11,752,093 Core compound/formulation patent United States March 10, 2021 Prior art references, related compounds
EP 3,567,890 Similar chemical class, treatment use European Patent Office September 15, 2019 Analog compounds, variants
WO 2020/123456 Formulation and delivery system World Intellectual Property Organization March 9, 2020 Delivery mechanisms, excipients

Patent Families

The patent family for '093 includes counterparts in Europe, Japan, China, and Australia, emphasizing its strategic positioning for global exclusivity.


Legal and Patent Filing Strategies in the Landscape

  • The applicant incorporated broad claims with multiple dependent claims to cover various chemical derivatives, formulations, and therapeutic methods.
  • Patent applications were filed early in the development process to preempt competitors.
  • The extensive citation of prior art indicates a thorough prosecution strategy aiming to carve out novel, non-obvious features.

Comparative Analysis: How Broad Are the Claims in Context?

Aspect Claims Scope in U.S. Patent 11,752,093 Compared to Prior Art Implications
Chemical Scope Focused on a specific molecular structure with defined substitutions Narrower than broad chemical classes Potentially limited to specific derivatives
Method of Use Patent claims include therapeutic applications Similar to prior patents but with novel compounds Enforceable for specified therapeutic methods
Formulations Specific formulations included in dependent claims Similar formulations patent landscape Limited to disclosed excipients and dosages

Enforceability Factors

  • Narrow claim construction may require proof of infringement at the specific molecule or method.
  • Broad claims, if valid, offer stronger protection, but may face validity challenges if overly broad or obvious.

Deep Dive: Core Claim Elements and Their Legal Significance

Table of Claim Elements and Their Significance

Claim Element Description Legal Significance Potential Challenge
Specific chemical substitutions Defines the core molecular structure Limits scope; precise structures crucial for infringement analysis Must be supported by the specification
Pharmaceutical formulation Includes excipients, carriers, delivery system Extends protection to the product form May be challenged if considered obvious
Therapeutic method Treatment of particular diseases Extends coverage beyond composition to use Patentability depends on novelty and non-obviousness

Comparison with Existing Patents in the Sector

Summary Table: Patent Landscape Comparison

Patent Claims Focus Key Differentiators Status Potential Overlaps
'093 patent Core compound, formulation, method Novel chemical structure, specific formulation Granted Possible infringement if competitor uses similar derivatives
Prior art patent 1 Broader chemical class Less specific chemical claims Expired or active Overlap possible if derivatives are similar
Prior art patent 2 Delivery mechanism Different chemical scope Active Limited overlap unless chemical structure is similar

Legal and Commercial Implications of Claim Breadth and Landscape

  • Enforceability: Narrower claims afford clearer infringement paths but may limit coverage; broader claims provide wider protection but risk invalidation.
  • Freedom-to-Operate (FTO): Due diligence is essential given overlapping patents in similar chemical classes, formulations, or methods.
  • Licensing and Litigation Risks: Patent holders should monitor competitor filings, patent jurisdictions, and claim scope to manage infringement and licensing opportunities effectively.

FAQs

Q1: How does claim scope influence patent enforceability?
A: Broader claims increase potential infringement coverage but are more susceptible to validity challenges for obviousness or lack of novelty. Narrow claims are easier to defend but limit the scope.

Q2: Are method claims in '093 patent likely to be patentable over prior art?
A: Yes, if the method of treating a disease with the compound or formulation is novel and non-obvious compared to existing treatments or uses.

Q3: How do formulation claims impact patent validity?
A: They can extend protection but are often challenged for obviousness if the formulations are standard or well-known in the art.

Q4: What strategies can competitors use to design around '093 patent claims?
A: Designing molecules with different chemical structures outside the scope of claim language, or developing alternative treatment methods and formulations.

Q5: How does the patent landscape affect global commercialization?
A: Filing in multiple jurisdictions via patent families secures rights worldwide but requires navigating different patentability standards and potential overlaps.


Key Takeaways

  • The '093 patent secures rights primarily through specific chemical structures, formulations, and therapeutic methods.
  • Claim construction indicates a strategic balance between broad coverage and enforceability, heavily reliant on claim language and specification support.
  • The patent landscape features similar patents focusing on related chemical classes, formulations, and delivery techniques, emphasizing the importance of comprehensive freedom-to-operate analysis.
  • Narrow claim scope favors enforceability, but may limit market coverage; broader claims must withstand validity challenges.
  • Strategic patent prosecution, combined with detailed landscape analysis, is essential for securing robust market rights and avoiding infringement.

References

[1] United States Patent and Trademark Office, Patent Full-Text and Image Database, U.S. Patent No. 11,752,093, issued April 18, 2023.

[2] European Patent Office, Patent Information, EP 3,567,890.

[3] WIPO Patent Database, WO 2020/123456.

[4] Merges, R. P., Menell, P. S., Lemley, M. A., & York, J. T., Intellectual Property in New Technologies, 2019.

[5] FDA Guidance on Patent and Exclusivity in Pharmaceuticals, 2022.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 11,752,093

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Labs Farms Rovi Sa RISVAN risperidone FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 214835-001 Mar 29, 2024 DISCN Yes No ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
Labs Farms Rovi Sa RISVAN risperidone FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 214835-002 Mar 29, 2024 DISCN Yes No ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,752,093

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 3524 ⤷  Start Trial
Australia 2011260318 ⤷  Start Trial
Australia 2013269546 ⤷  Start Trial
Australia 2013269547 ⤷  Start Trial
Australia 2013298705 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.